We trim our target price by ~4% as we cut 2021F/2022F NPAT-MI by 8.2%/6.5% following our lower projected profit from the NH3-NPK plant despite a 50-bp reduction in our cost of equity. We upgrade our rating from MARKET PERFORM to OUTPERFORM as DPM’s share